There is a body of evidence supporting GM-CSF as an important mediator in lung inflammation by upregulating TLR2, TLR4, and CD14 expression (22–24), and by boosting IL-6 and IL-1β production from macrophages (22, 25, 26). This evidence concerns the gene IL6 and inflammatory response.